GenEmbryomics is transforming IVF through advanced whole genome screening that detects abnormalities missed by conventional PGT testing. Our PGT-WGS technology sequences the complete genome of embryos to identify any abnormalities, as well as de novo mutations and false mosaicism. By comprehensively screening each embryo's genome, we enable the selection of only those with the highest potential for healthy implantation and pregnancy.